UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000025012 |
|---|---|
| Receipt number | R000028778 |
| Scientific Title | Evaluation of corneal crosslinking in progressive keratoconus |
| Date of disclosure of the study information | 2016/12/01 |
| Last modified on | 2019/06/16 19:59:23 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Evaluation of corneal crosslinking in progressive keratoconus
Acronym
Evaluation of corneal crosslinking
Scientific Title
Evaluation of corneal crosslinking in progressive keratoconus
Scientific Title:Acronym
Evaluation of corneal crosslinking
Region
| Japan |
Condition
Condition
keratoconus
Classification by specialty
| Ophthalmology |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To evaluate the safety and efficacy of corneal crosslinking
Basic objectives2
Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
visual acuity, manifest visual acuity, corneal thickness, corneal higher order aberrations
Key secondary outcomes
Base
Study type
Interventional
Study design
Basic design
Single arm
Randomization
Non-randomized
Randomization unit
Blinding
Open -no one is blinded
Control
Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
1
Purpose of intervention
Treatment
Type of intervention
| Maneuver |
Interventions/Control_1
corneal crosslinking
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 14 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
1. Increase in Steepest K-value more than 1.0D
2. Increase in manifest cylinder more than 1.0D
3. Increase in manifest spherical equivalent more than 1.0D
One of the above conditions was found within 24 months
and
the thinnest corneal thickness is 400 um or more.
Key exclusion criteria
The corneal thickness is less than 400 um .
Those who is implanted cardiac pacemaker, or other medical devices
Non of the conditions below are observed;
1 Increase in Steepest K-value more than 1.0D
2 Increase in manifest cylinder more than 1.0D
3 Increase in manifest spherical equivalent more than 1.0D
Those who have ocular disorders, such as infections, scars, ocular herpes, nystagmus etc.
those who have general diseases that can affect the corneal wound healing
Narrow angle
Those who is in pregnancy or breast-feeding
Occupations that are not allowed to undergo refractive surgeries
Age less than 14 year-old
Target sample size
100
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Takashi Kojima |
Organization
Nagoya Eye Clinic
Division name
Ophthalmology
Zip code
Address
3F Meitetsu Kanayama Build., 25-1 Namiyose-cho, Atsuta-ku, Nagoya, Japan
TEL
0120-758-049
kojima@chukyogroup.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Junko Sawada |
Organization
Nagoya Eye Clinic
Division name
Ethics committee
Zip code
Address
3F Meitetsu Kanayama Build., 25-1 Namiyose-cho, Atsuta-ku, Nagoya, Japan
TEL
0120-758-049
Homepage URL
nic-irb@lasik.jp
Sponsor or person
Institute
Nagoya Eye Clinic
Institute
Department
Personal name
Funding Source
Organization
Nagoya Eye Clinic
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
名古屋アイクリニック（愛知県）
Other administrative information
Date of disclosure of the study information
| 2016 | Year | 12 | Month | 01 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2011 | Year | 05 | Month | 28 | Day |
Date of IRB
| 2011 | Year | 05 | Month | 15 | Day |
Anticipated trial start date
| 2011 | Year | 06 | Month | 01 | Day |
Last follow-up date
| 2018 | Year | 03 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2016 | Year | 11 | Month | 27 | Day |
Last modified on
| 2019 | Year | 06 | Month | 16 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000028778
